171 related articles for article (PubMed ID: 31534347)
1. A temperature-sensitive phase-change hydrogel of topotecan achieves a long-term sustained antitumor effect on retinoblastoma cells.
Huo Y; Wang Q; Liu Y; Wang J; Li Q; Li Z; Dong Y; Huang Y; Wang L
Onco Targets Ther; 2019; 12():6069-6082. PubMed ID: 31534347
[TBL] [Abstract][Full Text] [Related]
2. A temperature-sensitive phase-change hydrogel of tamoxifen achieves the long-acting antitumor activation on breast cancer cells.
Meng D; Lei H; Zheng X; Han Y; Sun R; Zhao D; Liu R
Onco Targets Ther; 2019; 12():3919-3931. PubMed ID: 31213826
[No Abstract] [Full Text] [Related]
3. Hydrogel implants for transscleral drug delivery for retinoblastoma treatment.
Cocarta AI; Hobzova R; Sirc J; Cerna T; Hrabeta J; Svojgr K; Pochop P; Kodetova M; Jedelska J; Bakowsky U; Uhlik J
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109799. PubMed ID: 31349439
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma.
Delrish E; Jabbarvand M; Ghassemi F; Amoli FA; Atyabi F; Lashay A; Soleimani M; Aghajanpour L; Dinarvand R
Exp Eye Res; 2021 Mar; 204():108423. PubMed ID: 33453276
[TBL] [Abstract][Full Text] [Related]
5. Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model.
Hobzova R; Kodetova M; Pochop P; Uhlik J; Dunovska K; Svojgr K; Hrabeta J; Feriancikova B; Cocarta AI; Sirc J
Int J Pharm; 2021 Sep; 606():120832. PubMed ID: 34175379
[TBL] [Abstract][Full Text] [Related]
6. A novel long-sustaining system of apatinib for long-term inhibition of the proliferation of hepatocellular carcinoma cells.
Wang Y; Tang Z
Onco Targets Ther; 2018; 11():8529-8541. PubMed ID: 30555243
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
Liebes L; Potmesil M; Kim T; Pease D; Buckley M; Fry D; Cho J; Adler H; Dar K; Zeleniuch-Jacquotte A; Hochster H
Clin Cancer Res; 1998 Mar; 4(3):545-57. PubMed ID: 9533521
[TBL] [Abstract][Full Text] [Related]
8. Sustained-release hydrogels of topotecan for retinoblastoma.
Taich P; Moretton MA; Del Sole MJ; Winter U; Bernabeu E; Croxatto JO; Oppezzo J; Williams G; Chantada GL; Chiappetta DA; Schaiquevich P
Colloids Surf B Biointerfaces; 2016 Oct; 146():624-31. PubMed ID: 27429296
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway.
Xing L; Zhang L; Feng Y; Cui Z; Ding L
Biomed Pharmacother; 2018 Sep; 105():326-333. PubMed ID: 29864621
[TBL] [Abstract][Full Text] [Related]
10. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
[TBL] [Abstract][Full Text] [Related]
11. Formulation and optimization of topotecan nanoparticles: In vitro characterization, cytotoxicity, cellular uptake and pharmacokinetic outcomes.
Padhi S; Kapoor R; Verma D; Panda AK; Iqbal Z
J Photochem Photobiol B; 2018 Jun; 183():222-232. PubMed ID: 29729631
[TBL] [Abstract][Full Text] [Related]
12. A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.
Hammond LA; Eckardt JR; Ganapathi R; Burris HA; Rodriguez GA; Eckhardt SG; Rothenberg ML; Weiss GR; Kuhn JG; Hodges S; Von Hoff DD; Rowinsky EK
Clin Cancer Res; 1998 Jun; 4(6):1459-67. PubMed ID: 9626463
[TBL] [Abstract][Full Text] [Related]
13. Topotecan hydrochloride liposomes incorporated into thermosensitive hydrogel for sustained and efficient in situ therapy of H22 tumor in Kunming mice.
Xing J; Qi X; Jiang Y; Zhu X; Zhang Z; Qin X; Wu Z
Pharm Dev Technol; 2015 Nov; 20(7):812-819. PubMed ID: 24909735
[TBL] [Abstract][Full Text] [Related]
14. Folic acid-conjugated mesoporous silica nanoparticles for enhanced therapeutic efficacy of topotecan in retina cancers.
Qu W; Meng B; Yu Y; Wang S
Int J Nanomedicine; 2018; 13():4379-4389. PubMed ID: 30100721
[TBL] [Abstract][Full Text] [Related]
15. Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.
Hochster H; Liebes L; Speyer J; Sorich J; Taubes B; Oratz R; Wernz J; Chachoua A; Blum RH; Zeleniuch-Jacquotte A
Clin Cancer Res; 1997 Aug; 3(8):1245-52. PubMed ID: 9815806
[TBL] [Abstract][Full Text] [Related]
16. Topotecan increases topoisomerase IIalpha levels and sensitivity to treatment with etoposide in schedule-dependent process.
Whitacre CM; Zborowska E; Gordon NH; Mackay W; Berger NA
Cancer Res; 1997 Apr; 57(8):1425-8. PubMed ID: 9108439
[TBL] [Abstract][Full Text] [Related]
17. The current status of camptothecin analogues as antitumor agents.
Slichenmyer WJ; Rowinsky EK; Donehower RC; Kaufmann SH
J Natl Cancer Inst; 1993 Feb; 85(4):271-91. PubMed ID: 8381186
[TBL] [Abstract][Full Text] [Related]
18. Effect of topotecan on retinocytoma cell apoptosis and expression of Livin and PTEN.
Zhang M; Shan BE; Yuan NF; Liu W
Chin Med J (Engl); 2013 Jan; 126(2):340-4. PubMed ID: 23324287
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of docetaxel and topotecan in patients with solid tumors.
Tkaczuk KH; Zamboni WC; Tait NS; Meisenberg BR; Doyle LA; Edelman MJ; Hausner PF; Egorin MJ; Van Echo DA
Cancer Chemother Pharmacol; 2000; 46(6):442-8. PubMed ID: 11138457
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.
Ji X; Cheng L; Wei F; Li H; Wang M; Tian Y; Chen X; Wang Y; Wolf F; Li C; Huang Q
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5544-51. PubMed ID: 19608529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
